14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $2.94 $4.15 Thursday, 25th Apr 2024 CLRB stock ended at $3.02. This is 1.31% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 5.37% from a day low at $2.94 to a day high of $3.10.
90 days $2.94 $4.45
52 weeks $1.33 $4.45

Historical Cellectar Biosciences prices

Date Open High Low Close Volume
Apr 25, 2024 $3.07 $3.10 $2.94 $3.02 676 457
Apr 24, 2024 $3.09 $3.18 $3.00 $3.06 1 043 137
Apr 23, 2024 $3.17 $3.28 $3.11 $3.11 897 171
Apr 22, 2024 $3.03 $3.23 $2.97 $3.19 865 975
Apr 19, 2024 $3.01 $3.16 $3.01 $3.03 806 853
Apr 18, 2024 $3.21 $3.21 $3.01 $3.04 1 638 884
Apr 17, 2024 $3.32 $3.37 $3.17 $3.21 840 578
Apr 16, 2024 $3.51 $3.51 $3.23 $3.31 757 940
Apr 15, 2024 $3.51 $3.54 $3.28 $3.32 841 698
Apr 12, 2024 $3.69 $3.72 $3.48 $3.51 561 808
Apr 11, 2024 $3.49 $3.73 $3.49 $3.71 516 673
Apr 10, 2024 $3.66 $3.67 $3.45 $3.49 1 125 720
Apr 09, 2024 $3.78 $3.83 $3.69 $3.73 595 965
Apr 08, 2024 $3.84 $3.84 $3.67 $3.81 526 280
Apr 05, 2024 $3.72 $3.78 $3.68 $3.76 848 922
Apr 04, 2024 $4.03 $4.15 $3.71 $3.72 1 628 760
Apr 03, 2024 $4.00 $4.02 $3.92 $3.98 618 089
Apr 02, 2024 $3.87 $4.05 $3.75 $3.99 1 725 631
Apr 01, 2024 $4.05 $4.07 $3.82 $3.92 1 213 756
Mar 28, 2024 $3.84 $4.07 $3.79 $3.98 1 761 846
Mar 27, 2024 $3.83 $3.88 $3.53 $3.64 1 467 826
Mar 26, 2024 $3.88 $3.98 $3.78 $3.85 664 288
Mar 25, 2024 $4.05 $4.17 $3.85 $3.87 1 364 068
Mar 22, 2024 $3.84 $4.13 $3.81 $4.05 1 155 700
Mar 21, 2024 $3.80 $3.96 $3.76 $3.87 960 860
Click to get the best stock tips daily for free!

About Cellectar Biosciences

Cellectar Biosciences Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients;... CLRB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT